FDA approves new Hemophilia treatment

Volunteer for Clinical Trials

Have you ever thought about taking part in a Medical Trial? By registering your details with MedTrials.co.uk, we are able to send your details directly to companies who are looking for volunteers to take part in their medical research studies.

Information about you is kept on a register that CROs, Pharmaceutical companies and Clinical Investigators can access to contact you regarding individual studies.

Novo Nordisk has announced that the U.S. Food and Drug Administration (FDA) has approved the Biologics License Application for REBINYN® (Coagulation Factor IX (Recombinant), GlycoPEGylated) for the treatment of adults and children with hemophilia B. REBINYN® is the brand name for nonacog beta pegol, N9-GP. REBINYN® is indicated for on-demand treatment and control of bleeding episodes, […]

The post FDA approves new Hemophilia treatment appeared first on CenterWatch News Online.

News

Takeda Pharmaceutical and Schrödinger, a privately held company dedicated to revolutionizing drug discovery through advanced computational methods, announced the formation of a multi-target research collaboration directed to diseases that align with Takeda’s core therapeutic areas of interest. The unique collaboration will combine Schrödinger’s in silico platform-driven drug discovery capabilities with Takeda’s deep therapeutic area knowledge and expertise […]

Personalized cancer therapies are on the horizon thanks to a new genomic cancer research partnership between the Gene Editing Institute of Christiana Care Health System’s Helen F. Graham Cancer Center & Research Institute and the biotechnology company NovellusDx. The Gene Editing Institute has licensed its innovative gene editing technology to Jerusalem-based NovellusDx to improve the […]

Science Exchange is the first and only R&D outsourcing platform to receive EU-U.S. Privacy Shield Framework certification from the U.S. Department of Commerce. This certification demonstrates the company’s commitment to the protection and privacy of sensitive data shared by its customers and scientific service providers on the Science Exchange platform. Designed by the U.S. Department […]

Adimab, a global leader in the discovery and optimization of fully human monoclonal and bispecific antibodies, has entered into an agreement with Eli Lilly to transfer the Adimab Platform to Lilly for the discovery and optimization of antibody-based drugs in all therapeutic areas. This technology transfer expands an ongoing collaboration between the two companies that […]

Asia Pacific specialist CRO Novotech has expanded its business offering to include clinical trial site management organization (SMO) services with the launch of Novotech SMO Korea Co. Limited in South Korea. Novotech’s new business will train and provide clinical research coordinators (CRCs), as well as site management associates (SMAs) who will be able to support […]

The results of an international clinical trial, led in part by a UC Davis School of Medicine expert, have shown that a drug therapy for a severe type of muscular dystrophy holds promise for a… Powered by WPeMatico

Clinical Trials and Medical Trials recruitment in the UK

Volunteer for Clinical Trials

FDA approves new Hemophilia treatment

News

Takeda, Schrödinger form research collaboration

Christiana Care’s Gene Editing Institute, NovellusDx partner

Science Exchange R&D outsourcing platform to receive privacy certification

Adimab announces platform transfer with Lilly

Novotech launches new SMO business in South Korea

Clinical trial shows some promise for Duchenne muscular dystrophy drug